RxDrugOn

Medication Safety Solutions
Your Subtitle text
About Us

RxDrugOn is a privately held company founded in 2008. Our unique technology and the approach we have developed create an opportunity, for the first time, to introduce a low-cost, simple to use and easily accessible solution for reducing DDI (Drug-Drug Interaction), ADE (Adverse Drug Events) and feeding back medication usage statistics to pharmaceutical developers to aid in the development of new drugs. Our goal is to establish an accurate drug-list for patients (drugs they are consuming) empowering them to take an active role in their health. In addition, we believe we have created a win-win situation and have "something for everyone" in that we create value for all the stakeholders in the drug development, prescribing, distribution and use ecosystem.

Management Team

Major General (Ret.) Giora Eiland – Chairman

Major General Eiland headed the National Security Council and served as the National Security Adviser in the prime minister’s office from 2004 to 2006.   Today General Eiland holds several board and advisory positions with leading companies in the defense and high-tech industries. Between 2001 and 2003 General Eiland served as the head of the IDF Planning and Policy Directorate with responsibility for the IDF budget ($10B) and the IDF multi-year plan. General Eiland actively participated in the 1973 Yom Kippur War, the 1976 Entebbe rescue operation, and the 1982 Lebanon War. In 1999 he was appointed Head of the IDF Operations Directorate.

Yaron Front – CEO

Yaron is a veteran entrepreneur having founded 3 companies in the fields of enterprise software, medical information and medical devices. Before founding RxDrugOn Yaron served as the vice president of product management for Prizmasoft an enterprise software start-up. Prior to that Yaron was the senior product manager for Attunity, managing the company's flagship product "InFocus". Before Attunity Yaron co-founded Anota Ltd. in 1998 and served as the president and CEO of Anota for four years before it was acquired by Jacada Ltd. Before that Yaron founded Spectrum Dynamics (previously V-Target) an innovative medical device company in the field of non-invasive cancer diagnostics and treatment. Yaron has a keen understanding of the challenges new companies face in solving entrepreneurial and business challenges.


Ofer Haramati – Head of Israel Operations

Ofer Haramati brings to RxDrugOn over nearly 20 years of R&D experience, especially in development executive management, Data Connectivity, Data Integration, Multi Platform and heterogeneous environment, and reporting. Ofer previously held the position of Vice President of R&D at Prizmasoft. Prior to that Ofer was the Development Director of Attunity (NASDAQ: ATTU).   He led a large team of developers, with responsibility for the Research, Development, QA and Worldwide engineering support of 3 lines of products. Previously, Ofer held several managerial positions at Attunity’s R&D.

Dr. Allen Reiter – CTO

Dr. Reiter has been a software and database technologist since 1957. After coming to Israel from the US to help found the Technion Computer Science Department in 1969 (he was its second dean of the department), Dr. Reiter founded Reiter Software Systems (a software startup developing database products) which he headed from ‘78 until ‘89. He then joined Microsoft Corp. in Redmond, WA, where he was architect and development manager for the Access database engine, JET. In ‘94 Dr. Reiter joined Attunity Ltd., where he was the architect and manager for the company (later VP R&D at Attunity). In 2000 he left to become VP R&D for Enformia, developing an Internet portal platform product.